IFNA1 and cancer: Since it has been described that one hallmark of the SARS-CoV-2 infection is the ability of the virus to imbalance the IFN pathways [12, 15–17], this result surprisingly suggests that the concomitant presence of COVID-19 and cancer triggers a specific inflammatory response.